Home
Analyst Insights
Company News
Markets
Top Picks

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc (RARE) poses a Brand-New Opportunity for Investors with beta value of 0.21

October 2, 2025

Shaun Noe

Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) flaunted slowness of -0.30% at $29.99, as the Stock market unbolted on Wednesday, before settling ...

Most recent

Company News

Caesars Entertainment Inc (CZR) 20 Days SMA touch -0.50%: Odds are Looking very much in favour

Analyst Insights

Uranium Royalty Corp (UROY) surge 2.15% in a week: will this be a lucky break through?

Top Picks

Vista Gold Corp (VGZ) surge 8.50% in a week: will this be a lucky break through?

Markets

American Resources Corporation (AREC) Moves -2.96% Lower: These Numbers are Too Good to be True

Company News

Paramount Skydance Corp (PSKY) is set for another landmark as it hit the volume of 4.78 million

Analyst Insights

Kymera Therapeutics Inc (KYMR) last month performance of 34.33% certainly makes it a sizzling prospect

Newsdaemon.com is a business and stock news platform offering in-depth market coverage, aiming to expand readers’ understanding of public and private capital sharing through updates and detailed analysis.

Quick Links

About Us
Contact Us
Disclaimer
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled